ITFE-CKKER: NEW THERAPEUTIC APPROACH TO THE MUSCULAR DYSTROPHY OF BECKER (DMB) (Q2041423): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Changed an Item: Label in wikidata changed)
label / enlabel / en
 
ITFE-CKKER: NEW THERAPEUTIC APPROACH TO THE MUSCULAR DYSTROPHY OF BECKER (DMB)

Revision as of 08:41, 17 March 2020

Project in Italy financed by DG Regio
Language Label Description Also known as
English
ITFE-CKKER: NEW THERAPEUTIC APPROACH TO THE MUSCULAR DYSTROPHY OF BECKER (DMB)
Project in Italy financed by DG Regio

    Statements

    0 references
    1,618,074.93 Euro
    0 references
    3,236,149.85 Euro
    0 references
    50.00000015450459 percent
    0 references
    29 September 2016
    0 references
    1 November 2019
    0 references
    ITALFARMACO S.P.A.
    0 references
    FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
    0 references
    OPIS S.R.L.
    0 references
    0 references
    0 references
    0 references

    45°33'21.82"N, 9°12'50.44"E
    0 references
    LA DISTROFIA MUSCOLARE DI BECKER (DMB) UNA PATOLOGIA NEUROMUSCOLARE APPARTENENTE AL GRUPPO DELLE DISTROFINOPATIE, DI CUI LA DISTROFIA MUSCOLARE DI DUCHENNE (DMD) RAPPRESENTA LA FORMA PI GRAVE. LE DISTROFINOPATIE SONO CAUSATE DA MUTAZIONI A CARICO DEL GENE DELLA DISTROFINA, UNA PROTEINA FONDAMENTALE PER LA STABILIZZAZIONE DEL CITOSCHELETRO NELLE FIBRE MUSCOLARI SCHELETRICHE E CARDIACHE. LA DMB UNA MALATTIA RARA, DIAGNOSTICATA TRA I 10 E 30 ANNI DI ET, CHE COLPISCE I MASCHI, CON INCIDENZA D (Italian)
    0 references

    Identifiers

    E76D17000080009
    0 references